RNU7-167P

Across TCGA pan-cancer cohorts, RNU7-167P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU7-167P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU7-167P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-167P expression acts as an unfavorable survival marker.

CHOL, KIRP, and UCEC are the cancer types where RNU7-167P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
KIRP	OS	Tertile	II,III,IV	0.127	0.859	<.001	108	view →
UCEC	OS	Tertile	All	0.653	0.879	<.001	72	view →
ACC	OS	Tertile	All	0.214	0.802	.002	45	view →
LIHC	DFS	Tertile	II,III,IV	0.046	0.427	<.001	36	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU7-167P–CHOL (OS)

Open the CHOL breakdown →